THE Germany-based director of
the failed Gollmann-Bouw
Australian pharmacy automation
operation, Daniel Gollmann, has
confirmed that he is currently is en
route to Melbourne.
The first creditors meeting for the
collapsed company will be held at
10.30am today at L29, 600 Bourke
Street Melbourne, providing
creditors the opportunity to appoint
a committee.
The investigation into the
company’s failure is continuing,
with payment of unsecured
creditors’ accounts as at 15 July
postponed pending the outcome of
a second creditors meeting which
will be held on or before 19 August.
At that meeting the
administrators will formally present
the initial findings of their
investigation into the company.
Gollmann told PD overnight that
at this stage he’s unable to provide
any further information due to the
ongoing administration process.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jul 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.